The problem with this company is that the revenue is so small. How are they going to generate more? This is a major concern here.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025